The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome
Marcin R. Lener, Aniruddh Kashyap, Wojciech Kluźniak, Cezary Cybulski, Agnieszka Soluch, Sandra Pietrzak, Tomasz Huzarski, Jacek Gronwald, Jan Lubiński
Cancer Res Treat. 2017;49(2):430-436.   Published online 2016 Jul 28     DOI: https://doi.org/10.4143/crt.2016.217
Citations to this article as recorded by Crossref logo
CHEK2 germline variants identified in familial non-medullary thyroid cancer lead to impaired protein structure and function
Carolina Pires, Inês J. Marques, Mariana Valério, Ana Saramago, Paulo E. Santo, Sandra Santos, Margarida Silva, Margarida M. Moura, João Matos, Teresa Pereira, Rafael Cabrera, Diana Lousa, Valeriano Leite, Tiago M. Bandeiras, João B. Vicente, Branca M. Ca
Journal of Biological Chemistry.2024; : 105767.     CrossRef
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
Helen Hanson, Esteban Astiazaran-Symonds, Laura M. Amendola, Judith Balmaña, William D. Foulkes, Paul James, Susan Klugman, Joanne Ngeow, Rita Schmutzler, Nicoleta Voian, Myra J. Wick, Tuya Pal, Marc Tischkowitz, Douglas R. Stewart
Genetics in Medicine.2023; 25(10): 100870.     CrossRef
Understanding the Genetic Landscape of Pancreatic Ductal Adenocarcinoma to Support Personalized Medicine: A Systematic Review
Antonino Pantaleo, Giovanna Forte, Candida Fasano, Martina Lepore Signorile, Paola Sanese, Katia De Marco, Elisabetta Di Nicola, Marialaura Latrofa, Valentina Grossi, Vittoria Disciglio, Cristiano Simone
Cancers.2023; 16(1): 56.     CrossRef
Germline genetic variability in pancreatic cancer risk and prognosis
Manuel Gentiluomo, Federico Canzian, Andrea Nicolini, Federica Gemignani, Stefano Landi, Daniele Campa
Seminars in Cancer Biology.2022; 79: 105.     CrossRef
Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines
Cade Bennett, Mike Suguitan, John Abad, Akhil Chawla
Pancreatology.2022; 22(6): 719.     CrossRef
A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes
Esteban Astiazaran-Symonds, Jung Kim, Jeremy S. Haley, Sun Young Kim, H. Shanker Rao, Regeneron Genetics Center, David J. Carey, Douglas R. Stewart, Alisa M. Goldstein
Cancers.2022; 14(13): 3257.     CrossRef
Current status of inherited pancreatic cancer
Marek Olakowski, Łukasz Bułdak
Hereditary Cancer in Clinical Practice.2022;[Epub]     CrossRef
Genetic predisposition to male breast cancer in Poland
Marek Szwiec, Joanna Tomiczek-Szwiec, Wojciech Kluźniak, Dominika Wokołorczyk, Karolina Osowiecka, Robert Sibilski, Małgorzata Wachowiak, Jacek Gronwald, Helena Gronwald, Jan Lubiński, Cezary Cybulski, Steven A. Narod, Tomasz Huzarski
BMC Cancer.2021;[Epub]     CrossRef
Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients
Greet Wieme, Jan Kral, Toon Rosseel, Petra Zemankova, Bram Parton, Michal Vocka, Mattias Van Heetvelde, Petra Kleiblova, Bettina Blaumeiser, Jana Soukupova, Jenneke van den Ende, Petr Nehasil, Sabine Tejpar, Marianna Borecka, Encarna B. Gómez García, Mari
Cancers.2021; 13(17): 4430.     CrossRef
Assembling and Validating Bioinformatic Pipelines for Next-Generation Sequencing Clinical Assays
Jeffrey A SoRelle, Megan Wachsmann, Brandi L. Cantarel
Archives of Pathology & Laboratory Medicine.2020; 144(9): 1118.     CrossRef
Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer
Matthew B. Yurgelun, Anu B. Chittenden, Vicente Morales-Oyarvide, Douglas A. Rubinson, Richard F. Dunne, Margaret M. Kozak, Zhi Rong Qian, Marisa W. Welch, Lauren K. Brais, Annacarolina Da Silva, Justin L. Bui, Chen Yuan, Tingting Li, Wanwan Li, Atsuhiro
Genetics in Medicine.2019; 21(1): 213.     CrossRef
Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer
Akihiro Ohmoto, Shinichi Yachida, Chigusa Morizane
International Journal of Molecular Sciences.2019; 20(3): 561.     CrossRef
Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma
O. Obazee, L. Archibugi, A. Andriulli, P. Soucek, E. Małecka‐Panas, A. Ivanauskas, T. Johnson, M. Gazouli, T. Pausch, R. T. Lawlor, G. M. Cavestro, A. C. Milanetto, M. Di Leo, C. Pasquali, P. Hegyi, A. Szentesi, C. E. Radu, C. Gheorghe, G. E. Theodoropoul
International Journal of Cancer.2019; 145(3): 686.     CrossRef
Progress report: familial pancreatic cancer
Ioannis Mintziras, Detlef K. Bartsch
Familial Cancer.2019; 18(3): 359.     CrossRef
Spectrum of APC and MUTYH germ‐line mutations in Russian patients with colorectal malignancies
G.A. Yanus, T.A. Akhapkina, A.O. Ivantsov, E.V. Preobrazhenskaya, S.N. Aleksakhina, I.V. Bizin, A.P. Sokolenko, N.V. Mitiushkina, E.Sh. Kuligina, E.N. Suspitsin, A.R. Venina, M.M. Holmatov, O.A. Zaitseva, O.S. Yatsuk, D.V. Pashkov, A.M. Belyaev, A.V. Togo
Clinical Genetics.2018; 93(5): 1015.     CrossRef
Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines
Akihiro Ohmoto, Chigusa Morizane, Emi Kubo, Erina Takai, Hiroko Hosoi, Yasunari Sakamoto, Shunsuke Kondo, Hideki Ueno, Kazuaki Shimada, Shinichi Yachida, Takuji Okusaka
Journal of Gastroenterology.2018; 53(10): 1159.     CrossRef
Germline Variants and Risk for Pancreatic Cancer
Wei Zhan, Celeste A. Shelton, Phil J. Greer, Randall E. Brand, David C. Whitcomb
Pancreas.2018; 47(8): 924.     CrossRef